The platform features new nucleic acid sample prep and amplification technologies and will be developed for a wide range of DNA and RNA molecular diagnostic testing, including in oncology and infectious diseases, according to a Biocartis executive.
Becton Dickinson, Gen-Probe, and Cepheid updated JP Morgan Healthcare Conference attendees last week on their development timelines for upcoming nucleic acid testing platforms and assays.
In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.
